Clobetasol Propionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

72 API Suppliers, 14 USDMF, 13 CEP/COS, 4 JDMF, 12 EU WC, 17 KDMF, 16 NDC API, 40 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

35 Drugs in Development

35 Drugs in Development

FINISHED DOSAGE FORMULATIONS

227 FDF Dossiers, 99 FDA Orange Book, 56 Europe, 25 Canada, 3 Australia, 9 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.025%, AEROSOL, FOAM;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, SHAMPOO;TOPICAL - 0.05%, AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 4 DKSH, 8 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 ACG Worldwide, 9 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 3 Ideal Cures, 9 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Topical, 38 Coating Systems & Additives, 24 Solubilizers, 20 Thickeners and Stabilizers, 16 Controlled & Modified Release, 16 Parenteral, 15 Emulsifying Agents, 13 Surfactant & Foaming Agents, 11 Film Formers & Plasticizers, 7 Rheology Modifiers, 6 Granulation, 5 Taste Masking, 5 Direct Compression, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Fillers, Diluents & Binders, 4 API Stability Enhancers, 3 Lubricants & Glidants, 2 Coloring Agents, 1 Chewable & Orodispersible Aids, 1 Co-Processed Excipients, 1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

87 News #PharmaBuzz

87 News #PharmaBuzz

GLOBAL SALES INFORMATION

41 US Medicaid Prescriptions, 43 Regulatory FDF Prices

MARKET PLACE

24 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 4 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22013 / DOSAGE - AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CLOBETASOL PROPIONATE(UNII: 779619577M) (CLOBETASOL - UNII:ADN79D536H)	CLOBETASOL PROPIONATE	0.5mg in 1

Inactive Ingredients

Ingredient Name	Prestium Pharma, Inc.	Renaissance Pharma, Inc.
ANHYDROUS CITRIC ACID(XF417D3PSL)
CETYL ALCOHOL(936JST6JCN)
CYCLOMETHICONE(NMQ347994Z)
ISOPROPYL MYRISTATE(0RE8K4LNJS)
LIGHT MINERAL OIL(N6K5787QVP)
PETROLATUM(4T6H12BN9U)
PHENOXYETHANOL(HIE492ZZ3T)
POLYOXYL 20 CETOSTEARYL ETHER(YRC528SWUY)
POTASSIUM CITRATE(EE90ONI6FF)
PROPYLENE GLYCOL(6DC9Q167V3)
SORBITAN MONOLAURATE(6W9PS8B71J)
WATER(059QF0KO0R)

Drug Product Composition: Clobetasol Propionate